RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 154 filers reported holding RIGEL PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $75,243 | -16.3% | 69,669 | 0.0% | 0.00% | – |
| Q2 2023 | $89,873 | -4.8% | 69,669 | -2.6% | 0.00% | – |
| Q1 2023 | $94,373 | -12.0% | 71,495 | 0.0% | 0.00% | – |
| Q4 2022 | $107,243 | +20.6% | 71,495 | -5.1% | 0.00% | – |
| Q3 2022 | $88,921 | +4.3% | 75,357 | -0.1% | 0.00% | – |
| Q2 2022 | $85,219 | -62.2% | 75,415 | 0.0% | 0.00% | – |
| Q1 2022 | $225,491 | -11.6% | 75,415 | -21.6% | 0.00% | – |
| Q4 2021 | $255,000 | -25.7% | 96,175 | +1.7% | 0.00% | – |
| Q3 2021 | $343,000 | -22.0% | 94,599 | -6.7% | 0.00% | – |
| Q2 2021 | $440,000 | +27.5% | 101,433 | +0.5% | 0.00% | – |
| Q1 2021 | $345,000 | -6.5% | 100,886 | -4.4% | 0.00% | – |
| Q4 2020 | $369,000 | +49.4% | 105,531 | +2.7% | 0.00% | – |
| Q3 2020 | $247,000 | +28.6% | 102,730 | -3.8% | 0.00% | – |
| Q2 2020 | $192,000 | +11.6% | 106,776 | -3.4% | 0.00% | – |
| Q1 2020 | $172,000 | -23.2% | 110,527 | +5.7% | 0.00% | – |
| Q4 2019 | $224,000 | +9.8% | 104,567 | -6.0% | 0.00% | – |
| Q3 2019 | $204,000 | -29.7% | 111,296 | 0.0% | 0.00% | – |
| Q2 2019 | $290,000 | -1.0% | 111,296 | -2.3% | 0.00% | – |
| Q1 2019 | $293,000 | +6.2% | 113,896 | -5.3% | 0.00% | – |
| Q4 2018 | $276,000 | -25.4% | 120,217 | +4.5% | 0.00% | – |
| Q3 2018 | $370,000 | +1.1% | 115,068 | -10.9% | 0.00% | – |
| Q2 2018 | $366,000 | -8.0% | 129,140 | +14.8% | 0.00% | – |
| Q1 2018 | $398,000 | -11.0% | 112,528 | -2.4% | 0.00% | – |
| Q4 2017 | $447,000 | +73.3% | 115,304 | +13.5% | 0.00% | – |
| Q3 2017 | $258,000 | -4.4% | 101,569 | +2.6% | 0.00% | – |
| Q2 2017 | $270,000 | -4.3% | 99,023 | +16.2% | 0.00% | – |
| Q1 2017 | $282,000 | +65.9% | 85,185 | +19.1% | 0.00% | – |
| Q4 2016 | $170,000 | -32.5% | 71,500 | +4.1% | 0.00% | – |
| Q3 2016 | $252,000 | +56.5% | 68,705 | -4.9% | 0.00% | – |
| Q2 2016 | $161,000 | +22.9% | 72,243 | +13.2% | 0.00% | – |
| Q1 2016 | $131,000 | -30.3% | 63,815 | +2.5% | 0.00% | – |
| Q4 2015 | $188,000 | +26.2% | 62,279 | +3.7% | 0.00% | – |
| Q3 2015 | $149,000 | -21.2% | 60,042 | +2.3% | 0.00% | – |
| Q2 2015 | $189,000 | -15.6% | 58,678 | -6.5% | 0.00% | – |
| Q1 2015 | $224,000 | +58.9% | 62,738 | +1.2% | 0.00% | – |
| Q4 2014 | $141,000 | +22.6% | 62,006 | +5.3% | 0.00% | – |
| Q3 2014 | $115,000 | -45.8% | 58,885 | +0.4% | 0.00% | – |
| Q2 2014 | $212,000 | -20.3% | 58,666 | -14.6% | 0.00% | – |
| Q1 2014 | $266,000 | +36.4% | 68,724 | +0.4% | 0.00% | – |
| Q4 2013 | $195,000 | -21.7% | 68,468 | -1.5% | 0.00% | – |
| Q3 2013 | $249,000 | +6.9% | 69,545 | -0.4% | 0.00% | – |
| Q2 2013 | $233,000 | – | 69,799 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 9,105,691 | $30,140,000 | 5.99% |
| Sio Capital Management, LLC | 1,888,181 | $6,250,000 | 3.50% |
| DAFNA Capital Management LLC | 473,478 | $1,567,000 | 1.32% |
| Cormorant Asset Management, LP | 2,000,000 | $6,620,000 | 0.96% |
| Ghost Tree Capital, LLC | 1,100,000 | $3,641,000 | 0.68% |
| Rhenman & Partners Asset Management AB | 1,282,000 | $4,243,000 | 0.67% |
| Palo Alto Investors LP | 4,254,623 | $14,083,000 | 0.67% |
| NEA Management Company, LLC | 3,243,150 | $10,375,000 | 0.36% |
| Telemetry Investments, L.L.C. | 170,000 | $563,000 | 0.25% |
| NJ State Employees Deferred Compensation Plan | 355,000 | $1,175,000 | 0.22% |